Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial Overgrowth
Early Phase 1
Withdrawn
- Conditions
- Small Intestinal Bacterial Overgrowth
- Interventions
- Dietary Supplement: Novel Supplement Based Therapy
- First Posted Date
- 2018-02-05
- Last Posted Date
- 2021-01-12
- Lead Sponsor
- Atrium Innovations
- Registration Number
- NCT03420976
- Locations
- 🇺🇸
Good Medicine, Oxford, Ohio, United States
The Safety and Efficacy of an Enzyme Combination in Managing Knee Osteoarthritis Pain in Adults
Phase 2
Completed
- Conditions
- WobenzymOsteoarthritis
- Interventions
- First Posted Date
- 2014-03-17
- Last Posted Date
- 2014-03-17
- Lead Sponsor
- Atrium Innovations
- Target Recruit Count
- 150
- Registration Number
- NCT02088411
- Locations
- 🇩🇪
Mucos Pharma GmbH & Co, Oberhaching, Germany
Multi-Center Study Evaluating the Efficacy of Wobenzym(R)N in Treating Knee Osteoarthritis
Phase 2
Withdrawn
- Conditions
- Knee Osteoarthritis
- Interventions
- Dietary Supplement: Wobenzym® NDietary Supplement: Placebo
- First Posted Date
- 2009-09-10
- Last Posted Date
- 2016-07-12
- Lead Sponsor
- Atrium Innovations
- Registration Number
- NCT00974428
- Locations
- 🇨🇦
Groupe de Recherche en Rhumatologie et maladies osseuses, Quebec, Canada
🇨🇦Institut de Rhumatologie de Montréal, Montreal, Quebec, Canada
🇨🇦Centre de Recherche Musculo-Squelettique, Trois-Rivieres, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath